IMAGING (Q3989573): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed an Item: Fix Beneficiary from Netherlands)
(‎Changed an Item: Fix Beneficiary from Netherlands)
Property / beneficiary name (string)
 
Het Nederlands Kanker Instituut
Property / beneficiary name (string): Het Nederlands Kanker Instituut / rank
 
Normal rank
Property / beneficiary
 
Property / beneficiary: Q3987548 / rank
 
Normal rank

Revision as of 09:44, 16 December 2021

Project Q3989573 in Netherlands
Language Label Description Also known as
English
IMAGING
Project Q3989573 in Netherlands

    Statements

    0 references
    714,241.6 Euro
    0 references
    1,785,604.0 Euro
    0 references
    40.0 percent
    0 references
    1 January 2021
    0 references
    30 June 2023
    0 references
    Aidence BV
    0 references
    Erasmus Medisch Centrum
    0 references
    Het Nederlands Kanker Instituut
    0 references
    0 references
    0 references
    0 references

    52°21'33.70"N, 4°54'11.34"E
    0 references
    1017 WV
    0 references
    3000 CA
    0 references
    1006 BE
    0 references
    Een softwareoplossing genaamd “Veye VoluMarker” te ontwikkelen om de afmeting van longtumoren en mogelijke uitzaaiingen naar de lymfeklieren automatisch in CT-scans te bepalen, op basis van kunstmatige intelligentie (Artificial Intelligence). (Dutch)
    0 references
    Develop a software solution called “Veye VoluMarker” to automatically determine the size of lung tumours and possible metastases to the lymph nodes in CT scans, based on artificial intelligence (Artificial Intelligence). (English)
    15 December 2021
    0 references
    Développer une solution logicielle appelée «Veye VoluMarker» pour déterminer automatiquement la taille des tumeurs pulmonaires et des métastases possibles des ganglions lymphatiques dans les scans de tomodensitométrie, sur la base de l’intelligence artificielle (Intelligence Artificielle). (French)
    15 December 2021
    0 references
    Entwickeln Sie eine Softwarelösung namens „Veye VoluMarker“ zur automatischen Bestimmung der Größe von Lungentumoren und möglichen Metastasen zu den Lymphknoten in CT-Scans, basierend auf künstlicher Intelligenz (Künstliche Intelligenz). (German)
    15 December 2021
    0 references

    Identifiers

    OP-2014-2023-West-KVW-00308
    0 references